Yun Zhong, PhD

Contact Us

Yun Zhong, PhD is a Director and BTIG Biotechnology Analyst, specializing in gene therapy, genetic medicine, targeted therapy, rare disease and hematology. Prior to BTIG, Dr. Zhong was a Biotech Equity Research Analyst at Berenberg Capital Markets. Previously, he was Director within Biotech Equity Research at Janney Montgomery Scott. Earlier in his career, Dr. Zhong was a Vice President within Biotech Equity Research at SunTrust Robinson Humphrey, and a Biotech Equity Research Associate at Cowen. He earned a PhD in molecular biology and neuroscience from Rockefeller University, and an MS in biophysical engineering and BS in biophysical engineering from Osaka University.


Coverage Area

Company Ticker
Voyager Therapeutics, Inc. VYGR
Sarepta Therapeutics, Inc. SRPT
Magenta Therapeutics MGTA
uniQure NV QURE
Rocket Pharmaceuticals RCKT
Amicus Therapeutics FOLD
Passage Bio PASG
Taysha Gene Therapies TSHA
Selecta Biosciences SELB
Mereo Biopharma MREO
Anavex Life Sciences AVXL
Freeline Therapeutics FRLN
Graphite Bio GRPH